KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1
Oncology Reports · 2025
DOI: 10.3892/or.2025.8900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Jing Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medical, Lanzhou University, Lanzhou, Gansu 730000, P.R. China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Microtubule-Associated Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medical, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
- Department of Obstetrics, Lanzhou University Second Hospital, Lanzhou, Gansu 730000, P.R. China.
- Department of Pathology, Gansu Provincial Hospital, Lanzhou, Gansu 730000, P.R. China.
Zitieren
APA
Yang, J., He, R., Zhang, X., Wang, X., Liu, M., Liu, X., & Li, Y. (2025). KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1. Oncology Reports. https://doi.org/10.3892/or.2025.8900
Vancouver
Yang J, He R, Zhang X, Wang X, Liu M, Liu X, et al. KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1. Oncology Reports. 2025. doi:10.3892/or.2025.8900
BibTeX
@article{Yang2025,
author = {Yang, Jing and He, Rongxia and Zhang, Xiaoling and Wang, Xing and Liu, Min and Liu, Xiaolong and Li, Yulan},
title = {KLC3 activates PI3K/AKT signaling and promotes ovarian cancer cell proliferation and migration through COL3A1},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.8900}
}
EUVIMED